Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p2
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 2/191)
Character Range: 9465522–9481542

unable to take a solid dose form of a non-steroidal anti-inflammatory agent.
C4132               P4132          CN4132           Apixaban                                                                                                                                                                   Prevention of recurrent venous thromboembolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures - Streamlined Authority Code 4132
                                                                                                                                                                                                                               Continuing treatment
                                                    Rivaroxaban                                                                                                                                                                Patient must have a history of venous thromboembolism.

C4139               P4139          CN4139           Granisetron                                                                                                                                                                Nausea and vomiting
                                                                                                                                                                                                                               The condition must be associated with cytotoxic chemotherapy being used to treat malignancy which occurs within 48 hours of chemotherapy administration.
C4150               P4150          CN4150           Denosumab                                                                                                                                                                  Bone metastases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 4150
                                                                                                                                                                                                                               The condition must be due to castration-resistant prostate cancer.
C4158               P4158          CN4158           Denosumab                                                                                                                                                                  Bone metastases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 4158
                                                                                                                                                                                                                               The condition must be due to breast cancer.
C4159               P4159          CN4159           Naproxen                                                                                                                                                                   Chronic arthropathies (including osteoarthritis)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures - Streamlined Authority Code 4159
                                                                                                                                                                                                                               The condition must have an inflammatory component; AND
                                                                                                                                                                                                                               Patient must be unable to take a solid dose form of a non-steroidal anti-inflammatory agent.
C4171               P4171          CN4171           Macrogol 3350                                                                                                                                                              Constipation
                                                                                                                                                                                                                               Patient must have malignant neoplasia.
C4172               P4172          CN4172           Pregabalin                                                                                                                                                                 Neuropathic pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures - Streamlined Authority Code 4172
                                                                                                                                                                                                                               The condition must be refractory to treatment with other drugs.
C4173               P4173          CN4173           Macrogol 3350                                                                                                                                                              Chronic constipation
                                                                                                                                                                                                                               The condition must be inadequately controlled with first line interventions such as bulk-forming agents.
C4177               P4177          CN4177           Macrogol 3350                                                                                                                                                              Faecal impaction
                                                                                                                                                                                                                               The condition must be inadequately controlled with first line interventions such as bulk-forming agents.
C4179               P4179          CN4179           Macrogol 3350                                                                                                                                                              Constipation
                                                                                                                                                                                                                               Patient must be receiving palliative care.
C4180               P4180          CN4180           Macrogol 3350                                                                                                                                                              Constipation
                                                                                                                                                                                                                               Patient must be paraplegic, quadriplegic or have severe neurogenic impairment of bowel function; AND
                                                                                                                                                                                                                               The condition must be unresponsive to other oral therapies.
C4181               P4181          CN4181           Ciprofloxacin                                                                                                                                                              Bacterial keratitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures
                                                                                                                                                                                                                               Must be treated by an ophthalmologist or in consultation with an ophthalmologist.
                                                    Ofloxacin

C4190               P4190          CN4190           Rotigotine                                                                                                                                                                 Parkinson disease
                                                                                                                                                                                                                               The treatment must be as adjunctive therapy to a levodopa-decarboxylase inhibitor combination.
C4195               P4195          CN4195           Ciprofloxacin                                                                                                                                                              Bacterial keratitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures
                                                                                                                                                                                                                               Must be treated by an ophthalmologist or in consultation with an ophthalmologist.
                                                    Ofloxacin

C4204               P4204          CN4204           Rotigotine                                                                                                                                                                 Parkinson disease
                                                                                                                                                                                                                               The treatment must be as adjunctive therapy to a levodopa-decarboxylase inhibitor combination.
C4211               P4211          CN4211           Aprepitant                                                                                                                                                                 Nausea and vomiting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 4211
                                                                                                                                                                                                                               The condition must be associated with cytotoxic chemotherapy being used to treat malignancy; AND
                                                                                                                                                                                                                               The treatment must be in combination with a 5-hydroxytryptamine receptor (5HT3) antagonist and dexamethasone; AND
                                                                                                                                                                                                                               Patient must be scheduled to be administered a chemotherapy regimen that includes any 1 of the following agents:
                                                                                                                                                                                                                                altretamine; carmustine; cisplatin when a single dose constitutes a cycle of chemotherapy; cyclophosphamide at a dose of 1500 mg per square metre